Oxybutynin Hydrochloride Aspire

Oxybutynin hydrochloride, the active ingredient in Oxybutynin Hydrochloride Aspire, is an Antispasmodic presented as a 0.075%/tablet for oral use. It treats overactive bladder symptoms such as urgency, frequency and incontinence in adults.

GNH USA supplies Oxybutynin Hydrochloride Aspire as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxybutynin Hydrochloride is used within the urinary bladder therapeutic class: - Overactive bladder: Reduces urinary urgency, frequency and urge incontinence. - Detrusor overactivity: Relaxes the bladder muscle to improve storage capacity. - Neurogenic bladder dysfunction: Helps control involuntary bladder contractions.

Oxybutynin Hydrochloride may cause a range of adverse reactions.

Common Side Effects: - Dry mouth: Reduced salivary flow leading to a feeling of thirst. - Constipation: Slowed gastrointestinal motility. - Blurred vision: Transient visual disturbances. - Drowsiness: Mild sedation or fatigue. - Urinary retention: Difficulty initiating urination.

Serious or Rare Side Effects: - Tachycardia: Elevated heart rate that may require monitoring. - Severe allergic reaction: Rash, itching, swelling, or difficulty breathing. - Angle‑closure glaucoma: Sudden eye pain and visual loss. - Hepatic dysfunction: Elevated liver enzymes or jaundice. - Seizures: Uncommon but serious neurologic events.

When prescribing Oxybutynin Hydrochloride, consider the following safety measures: - Assess renal function: Adjust dosage in patients with renal impairment. - Review cardiovascular :   - Evaluate   - Monitor   - Store at ambient : keep  - - - -  -  -  -  -  -  -  -  -  -  -  -  -  -  - ",